Stock Alert: Caterpillar Rises To New 52-week High

By RTTNews Staff Writer   ✉   | Published:

Shares of Caterpillar Inc. (CAT) are rising more than 6 percent or $10.55 in Monday's morning trade at $171.84, after touching a new 52-week high of $176.36 despite no company-specific news.

U.S. stocks are advancing on Monday, with buying interest generated after Pfizer and BioNTech said data from the Phase 3 trial of their COVID-19 vaccine candidate showed it to be more than 90 percent effective in preventing coronavirus infection. Democratic candidate Joe Biden's presidential election victory also boosted stocks.

Caterpillar has traded in a range of $87.50 to $176.36 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Previous Story
Next Story
Editors Pick
FDA Authorizes First Serology Test That Detects COVID-19 Neutralizing Antibodies
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for GenScript USA Inc.'s "cPass SARS-CoV-2 Neutralization Antibody Detection Kit" as the world's first serology test that detects neutralizing antibodies (NAbs) from recent or prior SARS-CoV-2 infection.
Pfizer, BioNTech: COVID-19 Vaccine Candidate More Than 90% Effective
Pharmaceutical giant Pfizer Inc. (PFE) and German biotech firm BioNTech SE (BNTX) said Monday that their coronavirus vaccine candidate, BNT162b2, was found to be more than 90 percent effective in preventing COVID-19 among patients without prior evidence of infection. The results were based on the first interim efficacy analysis conducted from the vaccine's Phase 3 clinical study.
McDonald's Q3 Profit Rises, Tops View
McDonald's Corp. (MCD) reported a profit for the third-quarter that increased about 10 percent from last year, reflecting stronger operating performance in the U.S. due to higher sales-driven restaurant margins, partly offset by sales performance declines in the International Operated Markets and International Developmental Licensed Markets segments as a result of COVID-19.